“Addressing Metabolic Dysfunction‑Associated Steatotic Liver Disease (MASLD) in Endocrinology Settings in Canada: From Prevalence to Patient-Centered Management”, Can Diabetes Endocrinol Today, vol. 3, no. s01, pp. 2–8, Dec. 2025, doi: 10.58931/cdet.2025.3s0144.